PTC Therapeutics Management
Management criteria checks 3/4
PTC Therapeutics' CEO is Matt Klein, appointed in Mar 2023, has a tenure of 1.08 years. total yearly compensation is $5.01M, comprised of 11.9% salary and 88.1% bonuses, including company stock and options. directly owns 0.058% of the company’s shares, worth $1.14M. The average tenure of the management team and the board of directors is 7.2 years and 8.8 years respectively.
Key information
Matt Klein
Chief executive officer
US$5.0m
Total compensation
| CEO salary percentage | 11.9% |
| CEO tenure | 1.1yrs |
| CEO ownership | 0.06% |
| Management average tenure | 7.2yrs |
| Board average tenure | 8.8yrs |
Recent management updates
Recent updates
PTC Therapeutics, Inc. (NASDAQ:PTCT) Surges 27% Yet Its Low P/S Is No Reason For Excitement
Mar 03
PTC Therapeutics: Already Generates Revenues, But Lots Of Outstanding Options
Feb 11An Intrinsic Calculation For PTC Therapeutics, Inc. (NASDAQ:PTCT) Suggests It's 49% Undervalued
Jun 23Benign Growth For PTC Therapeutics, Inc. (NASDAQ:PTCT) Underpins Its Share Price
May 18An Intrinsic Calculation For PTC Therapeutics, Inc. (NASDAQ:PTCT) Suggests It's 49% Undervalued
Mar 02PTC pauses enrollment in mid-stage study for Huntington's disease candidate in U.S.
Oct 19PTC Therapeutics betas topline expectations, strengthens commercial portfolio
Aug 05PTC Therapeutics gene therapy Upstaza wins approval in EU for ultra-rare neuromuscular disorder
Jul 20PTC Therapeutics: DMD Trial News Unlikely To Restore Flagging Share Price
Jun 24Are PTC Therapeutics, Inc. (NASDAQ:PTCT) Investors Paying Above The Intrinsic Value?
May 27PTC Therapeutics: One Of The Leaders In The Treatment Of Rare Diseases
Apr 11Is Therapeutics (NASDAQ:PTCT) Using Debt Sensibly?
Feb 09PTC Therapeutics, Inc. (NASDAQ:PTCT) Shares Could Be 35% Below Their Intrinsic Value Estimate
Dec 27CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$627m |
| Sep 30 2023 | n/a | n/a | -US$642m |
| Jun 30 2023 | n/a | n/a | -US$618m |
| Mar 31 2023 | n/a | n/a | -US$571m |
| Dec 31 2022 | US$5m | US$598k | -US$559m |
Compensation vs Market: Matt's total compensation ($USD5.01M) is about average for companies of similar size in the US market ($USD5.55M).
Compensation vs Earnings: Insufficient data to compare Matt's compensation with company performance.
CEO
Matt Klein (50 yo)
1.1yrs
Tenure
US$5,009,299
Compensation
Dr. Matthew B. Klein, also known as Matt, M.D., MS, FACS, serves as Chief Executive Officer and Director of PTC Therapeutics, Inc. since March 24, 2023He served as an Independent Director at ClearPoint Neu...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 1.1yrs | US$5.01m | 0.058% $ 1.1m | |
| Co-Founder | 26.3yrs | US$7.16m | 0.097% $ 1.9m | |
| Co-Founder | 26.3yrs | US$553.96k | 0.016% $ 313.8k | |
| Chief Technical Operations Officer | 5.3yrs | US$2.67m | 0.054% $ 1.1m | |
| Chief Business Officer | 9yrs | US$2.99m | 0.025% $ 481.4k | |
| Chief Financial Officer | less than a year | no data | 0.010% $ 195.6k | |
| Senior VP | 4.8yrs | US$1.70m | 0.022% $ 433.3k | |
| Investor Relations Officer | no data | no data | no data | |
| Executive VP & Chief Legal Officer | 12.1yrs | US$4.29m | 0.064% $ 1.2m | |
| Vice President of Corporate Communications | no data | no data | no data | |
| Senior Vice President of Human Resources | 3.5yrs | no data | no data | |
| Senior Vice President of Global Regulatory Affairs | 9.3yrs | no data | no data |
7.2yrs
Average Tenure
59yo
Average Age
Experienced Management: PTCT's management team is seasoned and experienced (7.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 1.1yrs | US$5.01m | 0.058% $ 1.1m | |
| Co-Founder | 1.1yrs | US$7.16m | 0.097% $ 1.9m | |
| Co-Founder | 26.3yrs | US$553.96k | 0.016% $ 313.8k | |
| Independent Chairman of the Board | 22.7yrs | US$908.42k | 1.96% $ 38.2m | |
| Independent Director | 18.3yrs | US$488.46k | 0.0085% $ 165.1k | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 5.3yrs | US$491.46k | 0.0094% $ 183.0k | |
| Member of Scientific Advisory Board | 20.4yrs | no data | no data | |
| Independent Director | 8.8yrs | US$468.96k | 0.0085% $ 165.1k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 5.3yrs | US$463.96k | 0.0077% $ 149.1k |
8.8yrs
Average Tenure
63yo
Average Age
Experienced Board: PTCT's board of directors are considered experienced (8.8 years average tenure).